BACKGROUND: People with schizophrenia and their biological relatives have deficits in executive control processes such as inhibition and working memory as evidenced by performance abnormalities on antisaccade (AS) and ocular motor delayed response (ODR) tasks. METHODS: The present functional magnetic resonance imaging (fMRI) study was conducted to investigate brain activity associated with these putative indices of schizophrenia risk by: 1) directly comparing neural functioning in 15 schizophrenia patients, 13 of their first-degree biological relatives (primarily siblings), and 14 healthy participants; and 2) assessing executive function associated with volitional saccades by using a combination of AS and ODR tasks. RESULTS: Behavioral data showed that patients and relatives both made more volitional saccade errors. Imaging data demonstrated that within the context of preserved activity in some neural regions in patients and relatives, there were two distinct patterns of disruptions in other regions. First, there were deficits observed only in the schizophrenia group (decreased activity in lateral frontal eye field and supplementary eye field), suggesting a change associated with disease manifestation. Second, there were deficits observed in both patients and relatives (decreased activity in middle occipital gyrus, insula, cuneus, anterior cingulate, and Brodmann area 10 in prefrontal cortex), indicating a potential association with disease risk. CONCLUSIONS: Results indicate that decreased brain activation in regions involved in managing and evaluating early sensory and attention processing might be associated with poor volitional saccade control and risk for developing schizophrenia.
BACKGROUND:People with schizophrenia and their biological relatives have deficits in executive control processes such as inhibition and working memory as evidenced by performance abnormalities on antisaccade (AS) and ocular motor delayed response (ODR) tasks. METHODS: The present functional magnetic resonance imaging (fMRI) study was conducted to investigate brain activity associated with these putative indices of schizophrenia risk by: 1) directly comparing neural functioning in 15 schizophreniapatients, 13 of their first-degree biological relatives (primarily siblings), and 14 healthy participants; and 2) assessing executive function associated with volitional saccades by using a combination of AS and ODR tasks. RESULTS: Behavioral data showed that patients and relatives both made more volitional saccade errors. Imaging data demonstrated that within the context of preserved activity in some neural regions in patients and relatives, there were two distinct patterns of disruptions in other regions. First, there were deficits observed only in the schizophrenia group (decreased activity in lateral frontal eye field and supplementary eye field), suggesting a change associated with disease manifestation. Second, there were deficits observed in both patients and relatives (decreased activity in middle occipital gyrus, insula, cuneus, anterior cingulate, and Brodmann area 10 in prefrontal cortex), indicating a potential association with disease risk. CONCLUSIONS: Results indicate that decreased brain activation in regions involved in managing and evaluating early sensory and attention processing might be associated with poor volitional saccade control and risk for developing schizophrenia.
Authors: Mathijs Raemaekers; Nick F Ramsey; Matthijs Vink; Martin P van den Heuvel; Rene S Kahn Journal: Biol Psychiatry Date: 2005-09-13 Impact factor: 13.382
Authors: Jazmin Camchong; Kara A Dyckman; Caroline E Chapman; Nathan E Yanasak; Jennifer E McDowell Journal: Biol Psychiatry Date: 2006-02-03 Impact factor: 13.382
Authors: Adam L Boxer; Siobhan Garbutt; Katherine P Rankin; Joanna Hellmuth; John Neuhaus; Bruce L Miller; Stephen G Lisberger Journal: J Neurosci Date: 2006-06-07 Impact factor: 6.167
Authors: Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni Journal: Schizophr Bull Date: 2010-06-10 Impact factor: 9.306
Authors: Kara A Dyckman; Adrian K C Lee; Yigal Agam; Mark Vangel; Donald C Goff; Jason J S Barton; Dara S Manoach Journal: Schizophr Res Date: 2011-08-09 Impact factor: 4.939
Authors: Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer Journal: Biol Psychiatry Date: 2014-12-19 Impact factor: 13.382
Authors: Katharine N Thakkar; Jeffrey D Schall; Leanne Boucher; Gordon D Logan; Sohee Park Journal: Biol Psychiatry Date: 2010-10-23 Impact factor: 13.382
Authors: Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger Journal: Neuropsychopharmacology Date: 2010-03-31 Impact factor: 7.853
Authors: Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park Journal: Schizophr Bull Date: 2015-03 Impact factor: 9.306
Authors: Dara S Manoach; Adrian K C Lee; Matti S Hämäläinen; Kara A Dyckman; Jesse S Friedman; Mark Vangel; Donald C Goff; Jason J S Barton Journal: Biol Psychiatry Date: 2013-02-04 Impact factor: 13.382
Authors: M Steffens; C Neumann; A-M Kasparbauer; B Becker; B Weber; M A Mehta; R Hurlemann; U Ettinger Journal: Psychopharmacology (Berl) Date: 2018-10-24 Impact factor: 4.530